Heterogeneous antimicrobial activity in broncho-alveolar aspirates from mechanically ventilated intensive care unit

Jolien Seinen1,2, Willem Dieperink3, Solomon A Mekonnen1,4

  • 1Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Virulence
|October 31, 2019
PubMed

Insights

Sputum from intensive care unit (ICU) patients shows varied antimicrobial activity, influenced by antibiotics but not significantly by the microbiome. Higher antimicrobial activity surprisingly correlated with poorer patient outcomes.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Pneumonia involves lung alveoli filling with pus and fluid.
  • Ventilated patients are at risk, but not all develop pneumonia, suggesting protective factors in sputum.
  • The antimicrobial activity of sputum in lung infections is not well-characterized.

Purpose of the Study:

  • To quantify antimicrobial activity in broncho-alveolar aspirate (sputum) from intensive care unit (ICU) patients.
  • To correlate sputum antimicrobial activity with antibiotic levels, sputum microbiome, and patient characteristics.
  • To assess the role of sputum's antimicrobial properties in patient outcomes.

Main Methods:

  • Collected clinical metadata and sputum samples from 53 mechanically ventilated ICU patients.
  • Assessed sputum antimicrobial activity against *Streptococcus pneumoniae*, *Staphylococcus aureus*, and *Streptococcus anginosus*.
  • Analyzed correlations between antimicrobial activity, antibiotic concentrations, microbiome composition, and patient outcomes.

Main Results:

  • Significant variation in sputum antimicrobial activity was observed among patients.
  • Antibiotic therapy partially explained the observed antimicrobial activity.
  • The sputum microbiome's contribution to antimicrobial activity was minimal.
  • Antimicrobial activity inversely correlated with patient outcomes, likely due to disease severity.

Conclusions:

  • Sputum possesses variable antimicrobial activity in mechanically ventilated ICU patients.
  • Antibiotics are a key factor, while the microbiome plays a minor role in sputum's antimicrobial capacity.
  • Despite potential protective roles, increased sputum antimicrobial activity was associated with worse patient outcomes in this cohort.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
864
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
701
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
772
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
969
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
401